This article is part of CRN’s Associate Member Spotlight series and reflects the views, opinions, and expertise of the featured member company, Alkemist Labs. The content is provided for informational purposes only and does not represent the views, positions, or policies of the Council for Responsible Nutrition. Learn more: alkemist.com
As mushrooms continue to surge in popularity across supplements, functional foods, and wellness products, ensuring their quality and authenticity has become increasingly critical. Alkemist Labs’ “Mushrooms We’re Watching” highlights a growing concern within the industry: not all mushroom ingredients are what they claim to be.
In this video, Elan Sudberg Alkemist CEO identifies key quality issues affecting fungal ingredients, including misidentified species, incorrect fungal parts, and challenges associated with testing extracts. These issues are not just technical—they directly impact product efficacy, safety, and regulatory compliance.
One of the core challenges lies in the complexity of mushrooms themselves. Different parts of a fungus can yield different chemical profiles, making accurate identification essential. Additionally, extract-based products often present testing difficulties, requiring more sophisticated methods to verify authenticity and potency.
To address these risks, Alkemist emphasizes the importance of proactive quality control. By identifying high-risk ingredients early, manufacturers can avoid costly production delays, protect product integrity, and maintain compliance with evolving regulatory standards.
Ultimately, “Mushrooms We’re Watching” serves as both a resource and a warning, encouraging brands to take a more vigilant approach to sourcing and testing in an increasingly complex botanical.